Sabra Healthcare REIT Inc (NASDAQ: SBRA) has a higher price-to-earnings ratio of 44.53x compared to its average ratio. SBRA has 36-month beta value of 1.23. Analysts have mixed views on the stock, with 8 analysts rating it as a “buy,” 0 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for SBRA is 232.72M, and currently, short sellers hold a 7.72% ratio of that float. The average trading volume of SBRA on December 04, 2024 was 2.04M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SBRA) stock’s latest price update
Sabra Healthcare REIT Inc (NASDAQ: SBRA) has experienced a rise in its stock price by 0.44 compared to its previous closing price of 18.37. However, the company has seen a fall of -0.38% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-30 that Sabra Health Care REIT offers a compelling investment opportunity with a reasonable valuation, trading at 13.6x 2024 FFO and 12.9x 2025 FFO. The company benefits from strong industry fundamentals, including an aging population and growing demand for senior living and healthcare facilities. Q3’24 results showed robust performance with occupancy gains and NOI growth, particularly in the SHOP portfolio, indicating effective operational leverage.
SBRA’s Market Performance
Sabra Healthcare REIT Inc (SBRA) has seen a -0.38% fall in stock performance for the week, with a -1.02% decline in the past month and a 6.65% surge in the past quarter. The volatility ratio for the week is 2.25%, and the volatility levels for the past 30 days are at 2.71% for SBRA. The simple moving average for the last 20 days is -1.37% for SBRA’s stock, with a simple moving average of 14.87% for the last 200 days.
Analysts’ Opinion of SBRA
Many brokerage firms have already submitted their reports for SBRA stocks, with Wells Fargo repeating the rating for SBRA by listing it as a “Overweight.” The predicted price for SBRA in the upcoming period, according to Wells Fargo is $20 based on the research report published on October 01, 2024 of the current year 2024.
Citigroup, on the other hand, stated in their research note that they expect to see SBRA reach a price target of $20, previously predicting the price at $17. The rating they have provided for SBRA stocks is “Buy” according to the report published on September 13th, 2024.
Deutsche Bank gave a rating of “Buy” to SBRA, setting the target price at $21 in the report published on January 30th of the current year.
SBRA Trading at -0.88% from the 50-Day Moving Average
After a stumble in the market that brought SBRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -7.89% of loss for the given period.
Volatility was left at 2.71%, however, over the last 30 days, the volatility rate increased by 2.25%, as shares sank -1.23% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -3.91% lower at present.
During the last 5 trading sessions, SBRA fell by -0.38%, which changed the moving average for the period of 200-days by +34.18% in comparison to the 20-day moving average, which settled at $18.71. In addition, Sabra Healthcare REIT Inc saw 29.29% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SBRA starting from Cusack Catherine, who purchase 7,000 shares at the price of $14.43 back on May 22 ’24. After this action, Cusack Catherine now owns 46,385 shares of Sabra Healthcare REIT Inc, valued at $101,010 using the latest closing price.
FOSTER MICHAEL J, the Director of Sabra Healthcare REIT Inc, sale 10,000 shares at $14.68 during a trade that took place back on May 14 ’24, which means that FOSTER MICHAEL J is holding 63,923 shares at $146,830 based on the most recent closing price.
Stock Fundamentals for SBRA
Current profitability levels for the company are sitting at:
- 0.38 for the present operating margin
- 0.52 for the gross margin
The net margin for Sabra Healthcare REIT Inc stands at 0.14. The total capital return value is set at 0.07. Equity return is now at value 3.46, with 1.81 for asset returns.
Based on Sabra Healthcare REIT Inc (SBRA), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at 0.13. The debt to equity ratio resting at 0.9. The interest coverage ratio of the stock is 2.02.
Currently, EBITDA for the company is 311.81 million with net debt to EBITDA at 5.75. When we switch over and look at the enterprise to sales, we see a ratio of 9.81. The receivables turnover for the company is 5.71for trailing twelve months and the total asset turnover is 0.13.
Conclusion
To put it simply, Sabra Healthcare REIT Inc (SBRA) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
